Neuroone Medical Technologies (NMTC) Share-based Compensation Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 36.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.76% |
| Dec 31, 2025 | 5.90% |
| Sep 30, 2025 | 5.34% |
| Jun 30, 2025 | -6.48% |
| Mar 31, 2025 | -29.90% |
| Dec 31, 2024 | 9.91% |
| Sep 30, 2024 | 25.48% |
| Jun 30, 2024 | 14.24% |
| Mar 31, 2024 | 50.18% |
| Dec 31, 2023 | 2.82% |
| Sep 30, 2023 | 6.01% |
| Jun 30, 2023 | 15.99% |
| Mar 31, 2023 | 2.11% |
| Dec 31, 2022 | 47.82% |
| Sep 30, 2022 | -25.22% |
| Jun 30, 2022 | -70.92% |
| Mar 31, 2022 | -28.69% |
| Dec 31, 2021 | -17.39% |
| Sep 30, 2021 | 2.80% |
| Jun 30, 2021 | 129.06% |
| Mar 31, 2021 | -38.63% |
| Sep 30, 2020 | 442.84% |
| Jun 30, 2020 | 65.32% |
| Mar 31, 2020 | 657.34% |
| Jun 30, 2019 | 94.20% |
| Mar 31, 2019 | -72.40% |